Home › Myasthenia Gravis › Georgia › Augusta
Myasthenia Gravis clinical trials in Augusta, GA
4 studies for Myasthenia Gravis are looking for participants at sites in and around Augusta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
RecruitingPhase 2
- Augusta University, Neuroscience Center, Augusta
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
RecruitingPhase 3
- Site Number - 1043, Augusta
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
RecruitingPhase 3
- Wellstar MCG Health Medical Center, Augusta
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
RecruitingObservational study
- Clinical Trial Site, Augusta
About Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease that weakens the muscles under your control. Find out about MG causes, symptoms, and treatment.
More about Myasthenia Gravis on MedlinePlus
Myasthenia Gravis trials in other cities
- Tampa, FL12 studies
- Houston, TX11 studies
- Durham, NC10 studies
- Boca Raton, FL10 studies
- Columbus, OH8 studies
- Milwaukee, WI7 studies
- St. Louis, MO7 studies
- New York City, NY7 studies
- Miami, FL7 studies
- Washington, DC6 studies
- Columbia, MO6 studies
- Chattanooga, TN6 studies
Other studies in Augusta
- Acute Myeloid Leukemia10 studies
- Ovarian Cancer8 studies
- Endometrial Cancer7 studies
- Cancer (all types)7 studies
- Sickle Cell Disease5 studies
- Breast Cancer5 studies
- Blood Cancers4 studies
- Burkitt Lymphoma4 studies
- Diffuse Large B-Cell Lymphoma4 studies
- Chronic Myeloid Leukemia4 studies
- Non-Hodgkin Lymphoma4 studies
- Cervical Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.